Finance Watch: Syndax Has A Standout Post-ASH Offering As Peers Scramble For Cash

Others Are Less Lucky, Opting To Cut Programs, Jobs

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.